Clinical Trials Browser

Phase 1/2 × Advanced Biliary Tract Carcinoma × 90 days × Clear all

NCT07392541 2026-03-23

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

Phase 1/2 Recruiting

Gastrointestinal

Advanced Biliary Tract Carcinoma